Utilization of Nutrient Transporters SLC21A6 (OATP1B1) and SLC21A8 (OATP1B3) as Targets for Cancer Therapy - 1360
- Technology Benefits
- Inventionprovides a novel strategy for targeting increased nutrient uptake in cancercells as well as identifies microcystin as an existing toxic substrate withdemonstrated affinity for these particular nutrient transporters.
- Detailed Technology Description
- None
- *Abstract
-
None
- Country/Region
- USA

For more information, please click Here